Cargando…
Single enzyme loaded nanoparticles for combinational ultrasound-guided focused ultrasound ablation and hypoxia-relieved chemotherapy
Constructing nanosystems that synergistically combine therapeutic and diagnostic features is of great interest to the nanomedicine community but also remains a tremendous challenge. Methods: In this work, we report novel catalytic nanoparticles composed of the enzyme catalase, encapsulated in a poly...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857069/ https://www.ncbi.nlm.nih.gov/pubmed/31754380 http://dx.doi.org/10.7150/thno.37054 |
_version_ | 1783470692374675456 |
---|---|
author | Zhu, Jianzhi Li, Zhicong Zhang, Changchang Lin, Lizhou Cao, Shoupeng Che, Hailong Shi, Xiangyang Wang, Han van Hest, Jan C. M. |
author_facet | Zhu, Jianzhi Li, Zhicong Zhang, Changchang Lin, Lizhou Cao, Shoupeng Che, Hailong Shi, Xiangyang Wang, Han van Hest, Jan C. M. |
author_sort | Zhu, Jianzhi |
collection | PubMed |
description | Constructing nanosystems that synergistically combine therapeutic and diagnostic features is of great interest to the nanomedicine community but also remains a tremendous challenge. Methods: In this work, we report novel catalytic nanoparticles composed of the enzyme catalase, encapsulated in a polymer shell and surface decorated with pH-sensitive poly(ethylene glycol) (PEGylated nCAT). These nanoparticles were used as a promoter for ultrasound (US)-guided focused ultrasound (FUS) ablation and hypoxia alleviation for application in Doxorubicin-based chemotherapy. Results: The PEGylated nCAT produced highly effectively O(2) from endogenous H(2)O(2) to ameliorate the hypoxic and therefore poor-acoustic tumor environment. The generated O(2) was utilized as 1) a contrast agent for US imaging; 2) strengthening agent for FUS ablation and 3) normoxia inducer to enhance chemotherapeutic efficacy. The PEGylated nCAT exhibited favorable enzyme activity after long-term storage, and after exposure to proteolytic conditions and elevated temperatures. The pH-responsive PEGylation contributed on the one hand to an extended in vivo circulation time over 48 h and on the other hand enabled PEG cleavage in the vicinity of cancer cells to facilitate cellular uptake. Conclusion: The developed PEGylated nCAT can therefore effectively combine US-guided FUS and chemotherapy and can be regarded as a highly promising theranostic platform. |
format | Online Article Text |
id | pubmed-6857069 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-68570692019-11-21 Single enzyme loaded nanoparticles for combinational ultrasound-guided focused ultrasound ablation and hypoxia-relieved chemotherapy Zhu, Jianzhi Li, Zhicong Zhang, Changchang Lin, Lizhou Cao, Shoupeng Che, Hailong Shi, Xiangyang Wang, Han van Hest, Jan C. M. Theranostics Research Paper Constructing nanosystems that synergistically combine therapeutic and diagnostic features is of great interest to the nanomedicine community but also remains a tremendous challenge. Methods: In this work, we report novel catalytic nanoparticles composed of the enzyme catalase, encapsulated in a polymer shell and surface decorated with pH-sensitive poly(ethylene glycol) (PEGylated nCAT). These nanoparticles were used as a promoter for ultrasound (US)-guided focused ultrasound (FUS) ablation and hypoxia alleviation for application in Doxorubicin-based chemotherapy. Results: The PEGylated nCAT produced highly effectively O(2) from endogenous H(2)O(2) to ameliorate the hypoxic and therefore poor-acoustic tumor environment. The generated O(2) was utilized as 1) a contrast agent for US imaging; 2) strengthening agent for FUS ablation and 3) normoxia inducer to enhance chemotherapeutic efficacy. The PEGylated nCAT exhibited favorable enzyme activity after long-term storage, and after exposure to proteolytic conditions and elevated temperatures. The pH-responsive PEGylation contributed on the one hand to an extended in vivo circulation time over 48 h and on the other hand enabled PEG cleavage in the vicinity of cancer cells to facilitate cellular uptake. Conclusion: The developed PEGylated nCAT can therefore effectively combine US-guided FUS and chemotherapy and can be regarded as a highly promising theranostic platform. Ivyspring International Publisher 2019-10-17 /pmc/articles/PMC6857069/ /pubmed/31754380 http://dx.doi.org/10.7150/thno.37054 Text en © The author(s) This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. |
spellingShingle | Research Paper Zhu, Jianzhi Li, Zhicong Zhang, Changchang Lin, Lizhou Cao, Shoupeng Che, Hailong Shi, Xiangyang Wang, Han van Hest, Jan C. M. Single enzyme loaded nanoparticles for combinational ultrasound-guided focused ultrasound ablation and hypoxia-relieved chemotherapy |
title | Single enzyme loaded nanoparticles for combinational ultrasound-guided focused ultrasound ablation and hypoxia-relieved chemotherapy |
title_full | Single enzyme loaded nanoparticles for combinational ultrasound-guided focused ultrasound ablation and hypoxia-relieved chemotherapy |
title_fullStr | Single enzyme loaded nanoparticles for combinational ultrasound-guided focused ultrasound ablation and hypoxia-relieved chemotherapy |
title_full_unstemmed | Single enzyme loaded nanoparticles for combinational ultrasound-guided focused ultrasound ablation and hypoxia-relieved chemotherapy |
title_short | Single enzyme loaded nanoparticles for combinational ultrasound-guided focused ultrasound ablation and hypoxia-relieved chemotherapy |
title_sort | single enzyme loaded nanoparticles for combinational ultrasound-guided focused ultrasound ablation and hypoxia-relieved chemotherapy |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857069/ https://www.ncbi.nlm.nih.gov/pubmed/31754380 http://dx.doi.org/10.7150/thno.37054 |
work_keys_str_mv | AT zhujianzhi singleenzymeloadednanoparticlesforcombinationalultrasoundguidedfocusedultrasoundablationandhypoxiarelievedchemotherapy AT lizhicong singleenzymeloadednanoparticlesforcombinationalultrasoundguidedfocusedultrasoundablationandhypoxiarelievedchemotherapy AT zhangchangchang singleenzymeloadednanoparticlesforcombinationalultrasoundguidedfocusedultrasoundablationandhypoxiarelievedchemotherapy AT linlizhou singleenzymeloadednanoparticlesforcombinationalultrasoundguidedfocusedultrasoundablationandhypoxiarelievedchemotherapy AT caoshoupeng singleenzymeloadednanoparticlesforcombinationalultrasoundguidedfocusedultrasoundablationandhypoxiarelievedchemotherapy AT chehailong singleenzymeloadednanoparticlesforcombinationalultrasoundguidedfocusedultrasoundablationandhypoxiarelievedchemotherapy AT shixiangyang singleenzymeloadednanoparticlesforcombinationalultrasoundguidedfocusedultrasoundablationandhypoxiarelievedchemotherapy AT wanghan singleenzymeloadednanoparticlesforcombinationalultrasoundguidedfocusedultrasoundablationandhypoxiarelievedchemotherapy AT vanhestjancm singleenzymeloadednanoparticlesforcombinationalultrasoundguidedfocusedultrasoundablationandhypoxiarelievedchemotherapy |